SUBSCRIBE

Breaking News on Food & Beverage Development - North AmericaEU edition | Asian edition

News > Regulation

Cactus drink marketer to pay $3.5 million to settle FTC false advertising claims

Post a comment

By Hank Schultz

16-Jul-2014
Last updated on 16-Jul-2014 at 18:26 GMT

Cactus drink marketer to pay $3.5 million to settle FTC false advertising claims

The marketers of a cactus drink have agreed to pay $3.5 million to settle false advertising charges brought by the Federal Trade Commission. Such charges could be levied against many companies, said Denver-based attorney Justin Prochnow.

In this most recent case, TriVita, the company that markets a 32-ounce drink called Nopalea that is based on the Nopal cactus native to the Sonoran Desert, was alleged to have touted the drink on its websites as  "Inflammation Relief without a Prescription." The defendants' infomercials featuring celebrity endorser and former supermodel Cheryl Tiegs, market Nopalea as an "anti-inflammatory wellness drink" that relieves pain, reduces and relieves joint and muscle swelling, improves breathing and alleviates respiratory problems, and relieves skin conditions.  

Trivita's former chief science officer, Brazos Minshew, also appears in the infomercials and links inflammation to allergies, Alzheimer's disease, heart disease and diabetes.  He notes in one of the infomercials that "over 200 articles published and archived at the National Institutes of Health demonstrate one thing: the Nopal cactus will reduce inflammation."  The infomercials also feature testimonials by satisfied consumers who are actually paid employees of defendants, according to the complaint.

Consumer refunds

In the settlement, TriVita will pay $3.5 million in consumer refunds to settle the false advertising claims.  The list price for the company’s 32-oz beverage is $39.99.

According to FTC, the company violated Sections 5 and 12 of the FTC Act by:

 • making unsupported claims that Nopalea significantly improves breathing and relieves sinus infections and other respiratory conditions, and provides significant relief from pain, swelling of the joints and muscles, and psoriasis and other skin conditions.

 • making false claims that the health benefits of Nopalea were proven by clinical studies.

 • failing to disclose that supposedly ordinary consumer endorsers were in fact TriVita sales people who received commissions for selling the defendants' products.

Plenty of enforcement targets

“In the supplement industry these kinds of settlements happen a couple of times a year. There was that high profile case  a while back where the FTC shut down a series of acai weight loss websites,” Prochnow told NutraIngredients-USA.

Even with the big settlement with TriVita under its belt, there is a lot more the agency could be doing to police the industry, Prochnow said.  There is no shortage of companies willing to push the claims envelope or even to willingly step over the line.

“If you listen to my clients, the ratio of companies making false claims to those following the rules is way more than 10 to 1. I often hear from clients, what do you mean I can’t say that? I can go on the Internet and find any number websites that say the same thing.

“I tell them, I can only tell you what the speed limit is. It’s up to you to decide how fast you want to drive. Unfortunately, FTC doesn’t have enough radar guns,” he said.

Adequate substantiation

FTC is looking for what it considers to be adequate substantiation in the form of clinical data to back up any claim that is made.  The agency is not policing whether those claims comply with the category under which a product is marketed.  In other words, if a company were making a disease treatment claim on a dietary supplement, it might get into trouble with FDA but if it had adequate data to back the claim, it could be good to go with FTC.

“You saw that in the POM vs FTC case,” Prochnow said. “It’s not in the FTC’s jurisdiction to police whether it is a legitimate claim given the product category.  The fact that POM was making inflammation claims or arthritis claims was irrelevant to FTC’s decision.

"In general, when you are making claims for a wide variety of conditions, the more likely it is that you will come to FTC's attention. The agency would view a company that is marketing a cure all as one that might lack substantiation for those claims," he said.

Material connection

In addition to a lack of data to back up the drink’s purported health benefits, FTC took the company to task for the way it used testimonials in its advertising.  As a matter of law, Cheryl Tiegs does not have to disclose specifically that she was paid for her efforts;  it can be assumed that celebrity endorsers are compensated for the use of their images. But celebrities are supposed to believe the claims they make for products, Prochnow said.

It’s different with man-on-the-street type testimonials, he said.

“A company is free to use a testimonial from an employee, but you have to disclose that connection. You see this a lot when someone gets their brother-in-law, or a member of the board, to do a testimonial.  FTC’s point of view is that the consumers should have that information about the connection in order to decide how much weight to give that testimonial,” Prochnow said.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Post a comment

Comment title *
Your comment *
Your name *
Your email *

We will not publish your email on the site

I agree to Terms and Conditions

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...